A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolism.
Wang Q, Li S, Xu C, Hua A, Wang C, Xiong Y, Deng Q, Chen X, Yang T, Wan J, Ding ZY, Zhang BX, Yang X, Li Z.
Wang Q, et al. Among authors: li s, li z.
Pharmacol Res. 2023 Apr;190:106740. doi: 10.1016/j.phrs.2023.106740. Epub 2023 Mar 21.
Pharmacol Res. 2023.
PMID: 36958408
Free article.